BioSpace News Archive

Gain Therapeutics, Inc. today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Applied Molecular Transport Inc. today announced that the company will participate in the following investor events in September and October.

Brickell Biotech, Inc. today announced that it is scheduled to host a key opinion leader (KOL) webinar on DYRK1A (Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A)

NS Pharma, Inc. announced today an electronic poster presentation on long-term efficacy and safety data (interim analysis at 109 weeks) from the open-label extension (up to 192 weeks) of a Phase 2 study of VILTEPSO® (viltolarsen) injection at the World Muscle Society 2021 Virtual Conference being held September 20–24.

U.S. Special Presidential Envoy for Climate, John Kerry; U.S. Senator Ed Markey, D-Mass; Dr. Anthony Fauci; Dr. Rochelle Walensky; Jenny Slate; Dr. Ibram X. Kendi and U.S. Senator Elizabeth Warren, will headline free virtual conference discussing climate, innovation, healthcare, and equity

BIOREM Inc. today announced that at the special meeting of shareholders held on September 16, 2021 the shareholders approved the purchase for cancellation of 23,434,121 common shares of the Company from TPFG Environment Investment Limited

Tachyon Therapeutics, Inc. announces an abstract presentation of the Company’s lead product candidate, TACH101, at the European Society of Medical Oncology (“ESMO”) Annual Meeting. ESMO is being held virtually from September 16-21, 2021.

BeiGene Receives Positive CHMP Opinion for BRUKINSA ® (Zanubrutinib) for the Treatment of Adults with Waldenström’s Macroglobulinemia

Data from Corcept’s 178-patient, randomized, controlled, Phase 2 trial featured in a proffered paper oral presentation at ESMO 2021

MaxCyte, Inc. today announced that it is set to join the Russell 3000® and Russell 2000® indices, effective after the U.S. market opens on September 20, 2021